References
1. Song YZ, & Deng M. (2017). Sodium taurocholate cotransporting
polypeptide deficiency manifesting as cholestatic jaundice in early
infancy: a complicated case study.[J]. Zhongguo Dang Dai Er Ke Za
Zhi, 19(3):350–354.
2. Vaz FM. et al. (2015). Sodium taurocholate cotransporting polypeptide
(SLC10A1) deficiency: conjugated hypercholanemia without a clear
clinical phenotype.[J]. Hepatology, 61(1):260–267.
3. Yan H. et al.
(2014).
Viral entry of hepatitis B and D viruses and bile salts transportation
share common molecular determinants on sodium taurocholate
cotransporting polypeptide.[J]. Journal of Virology, 88(6):3273–84.
4. Deng LJ. et al. (2021). Clinical
characterization of NTCP deficiency in paediatric patients : A
case-control study based on SLC10A1 genotyping analysis.[J]. Liver
Int, 41(11): 2720-2728.
5. Hemminki K. et al. (2015). Thalassemia and sickle cell anemia in
Swedish immigrants: genetic diseases have become global.[J]. SAGE
open medicine. 3:2050312115613097.
6. Chong SS. et al. (2000).
Single-tube multiplex-PCR screen for
common deletional determinants of alpha-thalassemia.[J]. Blood,
95(1):360–2.
7.
Lee CG, & Ki CS. (2021). A Novel De Novo
Heterozygous ARID1A Missense Variant Cluster in cis
c.[5954C>G;6314C>T;6334C>T;6843G>C]
causes a Coffin–Siris Syndrome.[J]. Ann
Lab Med, 41(3):350-353.
8. Sekiguchi F. et al. (2019).
Genetic
abnormalities in a large cohort of Coffin-Siris syndrome
patients.[J]. J Hum Genet, 64(2):1173-86.
9. Vergano SS, & Deardorff MA. (2014). Clinical features, diagnostic
criteria, and management of Coffin-Siris syndrome.[J] .Am J Med
Genet C Semin Med Genet, 166(3): 252-6.
10. Lei C. (2015). Study on the
intervention of Mediterranean anemia in Guangxi Zhuang Region.[J].
China Contin Med Educ, 17:27-28.
Table 1. The 2-year follow-up records of physical, blood routine and
serology examination of the child.
Figure 1. A-C Sanger sequencing of exon 4 in SLC10A1 gene with the
heterozygous c.800C>T (p.Ser267Phe) mutation in the
heterozygous state in the proband and his mother (Red arrow). D-F Sanger
sequencing of exon 1 in SLC10A1 gene with the heterozygous
c.263T>C (p.lle88Thr) mutation in the heterozygous state in
the proband and his father (Red arrow). G-I Sanger sequencing of exon 8
in ARID1A gene with the
heterozygous
c.2698G>A (p.Ala900Thr) mutation in the heterozygous state
in the proband and his mother (Red arrow). J The 2-year follow-up
records of growth and development, facial and the fifth digit
phalanges/nails features of the child and his mother.